← Back to Screener
Organigram Global Inc. Common Shares (OGI)
Price$1.13
Value ScoreB
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-41.52%
Price vs S&P 500 (4W)-23.62%
VGM Score53.19
Market Capitalization$157.14M
All Metrics
Book Value / Share (Quarterly)$1.98
P/TBV (Annual)1.26x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)21.14%
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-42.15%
Gross Margin (TTM)3.77%
Net Profit Margin (TTM)-9.19%
EPS (TTM)$-0.14
10-Day Avg Trading Volume0.23M
EPS Excl Extra (TTM)$-0.14
Revenue Growth (5Y)24.46%
EPS (Annual)$-0.14
ROI (Annual)-5.80%
Gross Margin (Annual)6.64%
Net Profit Margin (5Y Avg)-73.33%
Cash / Share (Quarterly)$0.03
P/E Basic Excl Extra (TTM)11.18x
Revenue Growth QoQ (YoY)-8.85%
ROA (Last FY)-4.40%
Revenue Growth TTM (YoY)41.27%
EBITD / Share (TTM)$-0.10
ROE (5Y Avg)-28.70%
Operating Margin (TTM)-9.84%
Cash Flow / Share (Annual)$-0.13
P/B Ratio0.58x
P/B Ratio (Quarterly)0.68x
Net Income / Employee (Annual)$-15,803
EV / Revenue (TTM)1.00x
Net Interest Coverage (TTM)-0.46x
ROA (TTM)-4.63%
EV / EBITDA (TTM)52.73x
EPS Incl Extra (Annual)$-0.14
Current Ratio (Annual)2.26x
Quick Ratio (Quarterly)1.22x
3-Month Avg Trading Volume0.22M
52-Week Price Return-16.04%
P/E Incl Extra (TTM)11.18x
Revenue / Employee (TTM)$174,774
Tangible BV / Share (Quarterly)$1.77
P/S Ratio (Annual)0.84x
Asset Turnover (Annual)0.46x
52-Week High$3.09
Operating Margin (5Y Avg)-67.17%
EPS Excl Extra (Annual)$-0.14
CapEx CAGR (5Y)-26.35%
Tangible BV CAGR (5Y)0.20%
26-Week Price Return-25.59%
Quick Ratio (Annual)1.18x
13-Week Price Return-21.11%
Total Debt / Equity (Annual)0.22x
Current Ratio (Quarterly)2.82x
Enterprise Value$198.77M
Revenue / Share Growth (5Y)0.21%
Asset Turnover (TTM)0.50x
Book Value / Share Growth (5Y)-15.88%
Revenue / Employee (Annual)$165,278
Inventory Turnover (Annual)2.34x
Pretax Margin (Annual)-14.87%
Cash / Share (Annual)$0.16
3-Month Return Std Dev56.92%
Gross Margin (5Y Avg)-10.28%
Net Income / Employee (TTM)$-16,093
ROE (Last FY)-7.09%
Net Interest Coverage (Annual)-0.10x
EPS Basic Excl Extra (Annual)$-0.14
P/FCF (TTM)2.67x
Receivables Turnover (TTM)5.57x
Total Debt / Equity (Quarterly)0.17x
EPS Incl Extra (TTM)$-0.14
Receivables Turnover (Annual)5.39x
ROI (TTM)-5.82%
P/S Ratio (TTM)0.79x
Pretax Margin (5Y Avg)-74.88%
Revenue / Share (Annual)$1.47
Tangible BV / Share (Annual)$1.62
Forward P/E22.25x
Price vs S&P 500 (52W)-44.25%
P/E Ratio (TTM)11.18x
Year-to-Date Return-32.03%
5-Day Price Return-1.88%
EPS Normalized (Annual)$-0.14
ROA (5Y Avg)-24.98%
Net Profit Margin (Annual)-9.55%
Month-to-Date Return-17.80%
Cash Flow / Share (TTM)$-1.83
EBITD / Share (Annual)$-0.08
Operating Margin (Annual)-8.44%
LT Debt / Equity (Annual)0.20x
P/CF (TTM)21.53x
ROI (5Y Avg)-27.78%
P/E Excl Extra (TTM)11.18x
LT Debt / Equity (Quarterly)0.14x
EPS Basic Excl Extra (TTM)$-0.14
P/TBV (Quarterly)0.76x
P/B Ratio (Annual)1.08x
Inventory Turnover (TTM)2.11x
Pretax Margin (TTM)-14.18%
Book Value / Share (Annual)$1.88
Price vs S&P 500 (13W)-30.85%
Beta1.69x
Revenue / Share (TTM)$1.51
ROE (TTM)-6.83%
52-Week Low$1.44
vGradeB
gGradeC
mGradeD
vgmGradeC
Show chart for
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.89
3.89
3.89
3.89
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OGIOrganigram Global Inc. Common Shares | B | C | D | $1.13 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Organigram Global Inc is a licensed cannabis cultivator and manufacturer focused on Canada's adult recreational market, operating production facilities in Moncton, New Brunswick, Lac-Supérieur, Quebec, and a dedicated edibles facility in Winnipeg, Manitoba. The company maintains a diversified brand portfolio including Edison, SHRED, Monjour, and multiple other consumer-facing brands across cannabis and cannabis-derived products.